Skip to main content
. 2018 Jun 26;2018(6):CD002733. doi: 10.1002/14651858.CD002733.pub3

2.14. Analysis.

Comparison 2 Inactivated + live virus versus inactivated virus + placebo, Outcome 14 Participants with adverse effects (new upper respiratory tract symptoms).